This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: Guangzhou Dazhou Biomedicine Ltd., Shenox Pharmaceuticals, LLC. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Michael Mayersohn: Innovator in Transdermal Drug Delivery Systems
Introduction
Michael Mayersohn is a notable inventor based in Marana, AZ (US). He has made significant contributions to the field of drug delivery systems, particularly focusing on transdermal applications. With a total of 2 patents, his work aims to improve treatment options for various medical conditions.
Latest Patents
Mayersohn's latest patents include a transdermal drug delivery system for ketamine. This invention comprises transdermal delivery devices, such as monolithic transdermal patches, designed to treat diseases or disorders like depression, anxiety, and pain. Another significant patent is the ketamine transdermal delivery system, which focuses on formulations for treating major depressive disorder (MDD) and pain, incorporating abuse deterrent agents.
Career Highlights
Throughout his career, Michael Mayersohn has worked with various companies, including Shenox Pharmaceuticals, LLC and Guangzhou Dazhou Biomedicine Ltd. His expertise in drug delivery systems has positioned him as a key player in the pharmaceutical industry.
Collaborations
Mayersohn has collaborated with notable professionals in his field, including Huadong Tang and Hock Seng Tan. These partnerships have contributed to the advancement of his innovative projects.
Conclusion
Michael Mayersohn's work in transdermal drug delivery systems showcases his commitment to improving healthcare solutions. His inventions have the potential to significantly impact the treatment of mental health and pain management.